![]() |
|
|
RESÚMENES AGOSTO 2009 |
Child & Adolescent Disorders
(Haga un click en la información del journal
para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
3 - Development of Cortical
Asymmetry in Typically Developing Children and Its Disruption in
Attention-Deficit/Hyperactivity Disorder
Philip Shaw, Francois
Lalonde, Claude Lepage, Cara Rabin, Kristen Eckstrand, Wendy Sharp, Deanna
Greenstein, Alan Evans, J. N. Giedd, Judith Rapoport
Arch Gen Psychiatry. 2009;66(8):888-896
3! - Efficacy of Reboxetine in the Treatment of
Attention-Deficit/Hyperactivity Disorder in Boys With Intolerance to
Methylphenidate: An Open-Label, 8-Week, Methylphenidate-Controlled Trial
Cohen-Yavin,
Iris; Yoran-Hegesh, Roni; Strous, Rael D; Kotler, Moshe; Weizman, Abraham;
Spivak, Baruch
Clinical
Neuropharmacology: July/August 2009 - Volume 32 - Issue 4 - pp 179-182
3! - Early adversity and
5-HTT/BDNF genes: new evidence of gene–environment interactions on depressive
symptoms in a general population
M. Aguilera, B. Arias, M. Wichers, N.
Barrantes-Vidal, J. Moya, H. Villa, J. van Os, M. I. Ibáñez, M. A. Ruipérez, G.
Ortet and L. Fañanás
Psychological Medicine
(2009), 39:1425-1432
3! - Mood episodes and mood disorders: patterns of
incidence and conversion in the first three decades of life
Katja Beesdo, Michael Höfler, Ellen Leibenluft, Roselind Lieb,
Michael Bauer and Andrea Pfennig
Bipolar Disorders. Volume 11 Issue
6, Pages 637 - 649
5 - Limits of meta-analysis:
methylphenidate in the treatment of adult attention-deficit hyperactivity
disorder
M Koesters, T Becker, R Kilian, JM Fegert, S Weinmann
Journal of Psychopharmacology, Vol. 23, No. 7, 733-744
(2009)
3! - Body Mass Index Changes and Chronic Neuroleptic Drug
Treatment for Tourette Syndrome
Roosje S. Degrauw, Jason Z. Li and Donald L. Gilbert
Pediatric
Neurology. Volume 41, Issue 3, September 2009, Pages 183-186
3 - Use of Atomoxetine in Patients with Attention-Deficit
Hyperactivity Disorder and Co-Morbid Conditions
Dell'Agnello, Grazia; Zuddas,
Alessandro; Masi, Gabriele; Curatolo, Paolo; Besana, Dante; Rossi, Andrea
CNS
Drugs: 1 September 2009 - Volume 23 - Issue 9 - pp 739-753
3! - Meta-Analysis: Treatment of
Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic
Disorders
BLOCH,
MICHAEL H; PANZA, KAITLYN E; LANDEROS-WEISENBERGER, ANGELI; LECKMAN, JAMES F
3 - Sleep in Children With
Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Subjective and
Objective Studies
CORTESE,
SAMUELE; FARAONE, STEPHEN V; KONOFAL, ERIC; LECENDREUX, MICHEL
3 - Association of Family History of Autoimmune Diseases
and Autism Spectrum Disorders
Hjördís Ó. Atladóttir, Marianne G. Pedersen, Cand
Scient, Poul Thorsen, Preben Bo Mortensen, Bent Deleuran, William W. Eaton, and
Erik T. Parner
PEDIATRICS Vol. 124 No. 2 August 2009, pp. 687-694
3! - Dopamine and serotonin transporter genotypes moderate
sensitivity to maternal expressed emotion: the case of conduct and emotional
problems in attention deficit/hyperactivity disorder
Edmund J.S. Sonuga-Barke,
Robert D. Oades, Lamprini Psychogiou, Wai Chen,
Barbara Franke, Jan Buitelaar, Tobias Banaschewski, Richard P. Ebstein,
Michael Gil, Richard
Anney, Ana Miranda, Herbert Roeyers, Aribert Rothenberger, Joseph Sergeant,
Hans Christoph Steinhausen, Margaret Thompson, Philip Asherson, and Stephen V. Faraone
Journal of Child Psychology and Psychiatry. Volume 50
Issue 9, Pages 1052 - 1063
3 - White matter fractional anisotrophy differences and
correlates of diagnostic symptoms in autism
C. Cheung, S.E. Chua, V. Cheung, P.L. Khong , K.S. Tai,
T.K.W. Wong, T.P. Ho, and G.M.
McAlonan
Journal of Child Psychology and Psychiatry. Volume 50
Issue 9, Pages 1102 - 1112
3 - Depression begets depression: Comparing the
predictive utility of depression and anxiety symptoms to later depression
Kate Keenan, Xin Feng, Alison Hipwell, and Susan Klostermann
Journal of Child Psychology and Psychiatry. Volume 50
Issue 9, Pages 1167 - 1175
5 -
Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for
Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with
Developmental Disorders
Jaswinder
K. Ghuman, Michael G. Aman, Luc Lecavalier, Mark A. Riddle, Alan Gelenberg, Ron
Wright, Sydney Rice, Harinder S. Ghuman, Carolyn Fort
Journal
of Child and Adolescent Psychopharmacology. August 2009, 19(4): 329-339
5 -
A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese
Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Michihiro
Takahashi, Yasushi Takita, Kosuke Yamazaki, Takashi Hayashi, Hironobu Ichikawa,
Yasuko Kambayashi, Tatsuya Koeda, Junichi Oki, Kazuhiko Saito, Kenzo Takeshita,
Albert J. Allen
Journal
of Child and Adolescent Psychopharmacology. August 2009, 19(4): 341-350
5 -
Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules
Administered Once Daily to Children with Attention-Deficit/Hyperactivity
Disorder
Ann
C. Childress, Thomas Spencer, Frank Lopez, Ortrud Gerstner, Anuradha
Thulasiraman, Rafael Muniz, Anke Post
Journal
of Child and Adolescent Psychopharmacology. August 2009, 19(4): 351-361
3! -
Antipsychotic Medication in Children and Adolescents: A Descriptive Review of
the Effects on Prolactin Level and Associated Side Effects
Yvette
Roke, Peter N. van Harten, Annemieke M. Boot, Jan K. Buitelaar
Journal
of Child and Adolescent Psychopharmacology. August 2009, 19(4): 403-414
GRATIS 3 - Teenaged Brain: Part 1
John J. Medina
Psychiatric Times. 2009; Vol. 26 No. 8
| Regresar a RESÚMENES AGOSTO 2009 |
© 1999-2009 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.